Life SciencesCell BiologyMolecular BiologyCell SignalingGene ExpressionSignal TransductionCardiovascular Molecular PhysiologyCircadian Clock MechanismsCircadian DisruptionCircadian Gene ExpressionEndothelial ActivationEndothelial DysfunctionAtherosclerosis Molecular MechanismsAtherosclerosis RiskBmp Signaling InhibitionEndothelial-mesenchymal TransitionOxidative Stress InjuryPlaque InstabilityPlaque StabilityPlaque Vulnerability
Circadian rhythm disruption is intimately linked to atherosclerosis, and endothelial-to-mesenchymal transition (EndMT) is a major feature of atherosclerosis progression and unstable plaques. However, the mechanisms underlying the roles of Brain and Muscle ARNT-Like Protein-1 (BMAL1), an essential clock transcription activator, in EndMT and plaque instability have not been characterized. In the present study, we found a positive relationship among BMAL1 expression loss, EndMT, and plaque vulnerability in human carotid plaques. Furthermore, loss- and gain-of-function studies in human aortic endothelial cells (HAECs) revealed that BMAL1 inhibited oxidized low-density lipoprotein (oxLDL)-induced intracellular reactive oxygen species (ROS) accumulation and subsequent EndMT. Mechanistically, BMAL1 deficiency aggravated EndMT through BMP-mediated signaling. Collectively, our study demonstrates the underlying mechanism for the central role of BMAL1 loss in atherosclerosis progression and plaque stability transition promoted by oxidative stress, which can be targeted therapeutically to prevent the occurrence and progression of atherosclerosis.
28
Endothelial-to-mesenchymal transition drives atherosclerosis progression
Pei‐Yu Chen, Lingfeng Qin, Nicolas Baeyens et al. · Journal of Clinical Investigation · 2015 · 585 citations · Full text
Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
Benoît Ranchoux, Fabrice Antigny, Catherine Rücker‐Martin et al. · Circulation · 2015 · 572 citations · Full text